Financial results: ECS Botanics; Epsilon Healthcare by Martin Lane October 7, 2025February 21, 2026 ECS Botanics’ B2C division now accounts for more than half of the firm’s revenue in a […]
ECS posts $5.7m loss as impairments overshadow record harvest and B2C growth by Adam Sheldon September 1, 2025September 1, 2025
R&D ‘undercooked’ amid financial pressures but progress being made on industry collaboration, business leaders say by Steve Jones August 18, 2025August 18, 2025
Mixed sales for ECS Botanics as firm warns of import pressures by Steve Jones July 28, 2025July 28, 2025
News in brief: Althea completes medical cannabis asset sales; Argent begins clinical supply in Slovenia; ECS backs UWA trial for sleep apnoea by Adam Sheldon July 8, 2025July 9, 2025
News in brief: Carmen Doran to chair NZMCC; ECS Botanics tips record harvest; Elixinol and Epsilon raise capital by Martin Lane and Steve Jones May 21, 2025May 21, 2025
Consistent supply a priority for ECS despite share price ‘frustration’ by Steve Jones April 30, 2025May 1, 2025
Retail strategy delivering close to half of ECS Botanics sales revenue, Q3 figures show by Steve Jones April 28, 2025April 29, 2025
News in brief: ECS ups NAB facility for Terphogz launch; Helius boss departs by Steve Jones and Martin Lane April 14, 2025April 16, 2025
